# UWM Holdings Corp: financial statements, quarterly

UWMC · NYSE · CIK 1783398 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uwmc.md) · [Financials](/companies/uwmc/financials.md) · [Filings](/companies/uwmc/filings.md) · [Insiders](/companies/uwmc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uwmc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [677](/filings/0001783398-24-000044.md) | [740 d](/filings/0001783398-26-000013.md) | [586](/filings/0001783398-25-000025.md) | [622](/filings/0001783398-25-000035.md) | [746](/filings/0001783398-25-000050.md) | [721 d](/filings/0001783398-26-000013.md) | [613](/filings/0001783398-26-000051.md) | [759](/filings/0001783398-26-000117.md) | [843](/filings/0001783398-25-000050.md) | [945 d](/filings/0001783398-26-000013.md) | [901](/filings/0001783398-26-000051.md) | [888](/filings/0001783398-26-000117.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [93.7](/filings/0001783398-23-000044.md) | [80.8 d](/filings/0001783398-24-000012.md) | [98.7](/filings/0001783398-24-000021.md) | [109](/filings/0001783398-24-000038.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.7](/filings/0001783398-24-000044.md) | [(7.5) d](/filings/0001783398-26-000013.md) | [3.7](/filings/0001783398-25-000025.md) | [0.8](/filings/0001783398-25-000035.md) | [0.3](/filings/0001783398-25-000050.md) | [1.7 d](/filings/0001783398-26-000013.md) | [(13.8)](/filings/0001783398-26-000051.md) | [14.9](/filings/0001783398-26-000117.md) | [0.6](/filings/0001783398-25-000050.md) | [5.1 d](/filings/0001783398-26-000013.md) | [7.1](/filings/0001783398-26-000051.md) | [(21.0)](/filings/0001783398-26-000117.md) |
| Net income | $m | [18.2](/filings/0001783398-24-000044.md) | [(27.1) d](/filings/0001783398-26-000013.md) | [8.7](/filings/0001783398-25-000025.md) | [3.1](/filings/0001783398-25-000035.md) | [(6.3)](/filings/0001783398-25-000050.md) | [8.9 d](/filings/0001783398-26-000013.md) | [(13.7)](/filings/0001783398-26-000051.md) | [22.9](/filings/0001783398-26-000117.md) | [(1.3)](/filings/0001783398-25-000050.md) | [19.4 d](/filings/0001783398-26-000013.md) | [25.3](/filings/0001783398-26-000051.md) | [(80.6)](/filings/0001783398-26-000117.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001783398-24-000044.md) | not reported | [0.09](/filings/0001783398-25-000025.md) | [0.03](/filings/0001783398-25-000035.md) | [(0.06)](/filings/0001783398-25-000050.md) | not reported | [(0.12)](/filings/0001783398-26-000051.md) | [0.11](/filings/0001783398-26-000117.md) | [(0.01)](/filings/0001783398-25-000050.md) | not reported | [0.09](/filings/0001783398-26-000051.md) | [(0.24)](/filings/0001783398-26-000117.md) |
| Basic EPS | $ per share | [0.20](/filings/0001783398-24-000044.md) | not reported | [0.09](/filings/0001783398-25-000025.md) | [0.03](/filings/0001783398-25-000035.md) | [(0.06)](/filings/0001783398-25-000050.md) | not reported | [(0.08)](/filings/0001783398-26-000051.md) | [0.11](/filings/0001783398-26-000117.md) | [(0.01)](/filings/0001783398-25-000050.md) | not reported | [0.09](/filings/0001783398-26-000051.md) | [(0.24)](/filings/0001783398-26-000117.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0001783398-23-000044.md) | [0.5](/filings/0001783398-25-000007.md) | [0.6](/filings/0001783398-24-000021.md) | [0.7](/filings/0001783398-24-000038.md) | [0.6](/filings/0001783398-24-000044.md) | [0.5](/filings/0001783398-26-000013.md) | [0.5](/filings/0001783398-25-000025.md) | [0.5](/filings/0001783398-25-000035.md) | [0.9](/filings/0001783398-25-000050.md) | [0.5](/filings/0001783398-26-000117.md) | [0.4](/filings/0001783398-26-000051.md) | [0.5](/filings/0001783398-26-000117.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [12.2](/filings/0001783398-23-000044.md) | [11.9](/filings/0001783398-25-000007.md) | [12.8](/filings/0001783398-24-000021.md) | [12.9](/filings/0001783398-24-000038.md) | [15.1](/filings/0001783398-24-000044.md) | [15.7](/filings/0001783398-26-000013.md) | [14.0](/filings/0001783398-25-000025.md) | [13.9](/filings/0001783398-25-000035.md) | [17.0](/filings/0001783398-25-000050.md) | [16.9](/filings/0001783398-26-000117.md) | [19.3](/filings/0001783398-26-000051.md) | [17.9](/filings/0001783398-26-000117.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $bn | [9.1](/filings/0001783398-23-000044.md) | [9.4](/filings/0001783398-25-000007.md) | [10.3](/filings/0001783398-24-000021.md) | [10.6](/filings/0001783398-24-000038.md) | [12.9](/filings/0001783398-24-000044.md) | [13.6](/filings/0001783398-26-000013.md) | [12.4](/filings/0001783398-25-000025.md) | [12.1](/filings/0001783398-25-000035.md) | [15.4](/filings/0001783398-25-000050.md) | [15.3](/filings/0001783398-26-000117.md) | [17.7](/filings/0001783398-26-000051.md) | [17.0](/filings/0001783398-26-000117.md) |
| Long-term debt | $bn | [2.0](/filings/0001783398-23-000044.md) | [2.0](/filings/0001783398-25-000007.md) | [2.0](/filings/0001783398-24-000021.md) | [2.0](/filings/0001783398-24-000038.md) | [2.0](/filings/0001783398-24-000044.md) | [2.8](/filings/0001783398-26-000013.md) | [2.8](/filings/0001783398-25-000025.md) | [2.8](/filings/0001783398-25-000035.md) | [3.8](/filings/0001783398-25-000050.md) | [3.0](/filings/0001783398-26-000117.md) | [3.0](/filings/0001783398-26-000051.md) | [3.0](/filings/0001783398-26-000117.md) |
| Shareholders' equity | $bn | [3.1](/filings/0001783398-24-000044.md) | [2.5](/filings/0001783398-26-000013.md) | [2.5](/filings/0001783398-25-000050.md) | [2.3](/filings/0001783398-25-000050.md) | [2.2](/filings/0001783398-25-000050.md) | [2.1](/filings/0001783398-26-000117.md) | [1.6](/filings/0001783398-26-000117.md) | [1.7](/filings/0001783398-26-000117.md) | [1.6](/filings/0001783398-25-000050.md) | [1.6](/filings/0001783398-26-000117.md) | [1.6](/filings/0001783398-26-000117.md) | [1.0](/filings/0001783398-26-000117.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [346 d](/filings/0001783398-24-000044.md) | [(329) d](/filings/0001783398-26-000013.md) | [(2,203)](/filings/0001783398-25-000025.md) | [(1,317) d](/filings/0001783398-25-000035.md) | [(2,178) d](/filings/0001783398-25-000050.md) | [(543) d](/filings/0001783398-26-000013.md) | [594](/filings/0001783398-26-000051.md) | [(266) d](/filings/0001783398-26-000117.md) | [(3,079) d](/filings/0001783398-25-000050.md) | [104 d](/filings/0001783398-26-000013.md) | [(2,230)](/filings/0001783398-26-000051.md) | [344 d](/filings/0001783398-26-000117.md) |
| Capital expenditure | $m | [6.3 d](/filings/0001783398-24-000044.md) | [6.8 d](/filings/0001783398-26-000013.md) | [7.0](/filings/0001783398-25-000025.md) | [11.9 d](/filings/0001783398-25-000035.md) | [12.3 d](/filings/0001783398-25-000050.md) | [8.3 d](/filings/0001783398-26-000013.md) | [17.8](/filings/0001783398-26-000051.md) | [24.2 d](/filings/0001783398-26-000117.md) | [10.4 d](/filings/0001783398-25-000050.md) | [21.7 d](/filings/0001783398-26-000013.md) | [19.1](/filings/0001783398-26-000051.md) | [9.5 d](/filings/0001783398-26-000117.md) |
| Dividends paid | $m | [9.3 d](/filings/0001783398-24-000044.md) | [9.4 d](/filings/0001783398-26-000013.md) | [9.4](/filings/0001783398-25-000025.md) | [9.5 d](/filings/0001783398-25-000035.md) | [9.6 d](/filings/0001783398-25-000050.md) | [11.3 d](/filings/0001783398-26-000013.md) | [15.8](/filings/0001783398-26-000051.md) | [18.8 d](/filings/0001783398-26-000117.md) | [20.6 d](/filings/0001783398-25-000050.md) | [23.4 d](/filings/0001783398-26-000013.md) | [26.8](/filings/0001783398-26-000051.md) | [33.0 d](/filings/0001783398-26-000117.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2023 (2023-03-31) | Q4 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [92.6](/filings/0001783398-23-000044.md) | [92.9](/filings/0001783398-24-000021.md) | [93.1](/filings/0001783398-24-000038.md) | [1,597](/filings/0001783398-24-000044.md) | [1,599](/filings/0001783398-25-000025.md) | [95.4](/filings/0001783398-25-000035.md) | [99.8](/filings/0001783398-25-000050.md) | [1,598](/filings/0001783398-26-000051.md) | [202](/filings/0001783398-26-000117.md) | [221](/filings/0001783398-25-000050.md) | [1,600](/filings/0001783398-26-000051.md) | [338](/filings/0001783398-26-000117.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 103,104,205 at 2021-03-18, from the cover of the [10-K filed 2021-03-22](/filings/0001564590-21-014601.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.